Insider trades
Levy Adam Scott, CFO of Mineralys Therapeutics MLYS, has filed 1 purchase and 23 sales on the open market. Over the past 12 months that comes to a net sale of $6.2M. The latest trade was on 02/19.
Levy Adam Scott
CFO and Secretary
- Company
- Mineralys Therapeutics MLYS
- First filing
- 23/02/13
- Trades
- 38 trades
- Buys / sales
- 1 / 23
- 12-month net buying
- −$6.2M
- Last trade
- 02/19
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
| Open-market sale10b5-1 plan | 01/12 | 01/13 | 10,758 sh | $32.14 | $345,762.12 | −55.5% | |
| Open-market sale | 25/11/11 | 25/11/13 | 119,524 sh9 trades | $44.87avg. | $5,363,596.75 | −86.0% | |
| Open-market sale10b5-1 plan | 25/10/13 | 25/10/15 | 10,758 sh2 trades | $42.01avg. | $451,981.32 | −8.4% | |
| Open-market sale | 25/07/28–25/07/30 | 25/07/30 | 73,678 sh4 trades | $14.62avg. | $1,077,327.34 | −35.7% | |
| Open-market sale10b5-1 plan | 25/07/11 | 25/07/15 | 10,758 sh | $14.45 | $155,453.1 | −4.9% | |
| Open-market sale10b5-1 plan | 25/04/11 | 25/04/15 | 10,757 sh | $12.06 | $129,729.42 | −4.8% | |
| Open-market sale10b5-1 plan | 25/01/13 | 25/01/15 | 10,757 sh2 trades | $9.10avg. | $97,835.13 | −4.5% | |
| Open-market sale10b5-1 plan | 24/10/11 | 24/10/15 | 10,757 sh | $13.57 | $145,972.49 | −4.3% | |
| Open-market sale10b5-1 plan | 24/07/11 | 24/07/12 | 10,757 sh | $13.14 | $141,346.98 | −4.2% | |
| Open-market sale10b5-1 plan | 24/06/11 | 24/06/13 | 96,815 sh | $12.94 | $1,252,786.1 | −27.5% | |
| Open-market buy | 23/02/14 | 23/02/16 | 6,250 sh | $16.00 | $100,000 | +1.8% |